EXCLUSIVE: Where to Access HIV Wonder Injection, Lenacapavir in Eastern Uganda

The Ministry of Health has published Health Centres across the country where Lenacapavir is offered. The List that includes all Regional and General Hospitals also includes some Health Centre III’s.

Lenacapavir is a first-in-class, long-acting HIV medication used to treat multi-drug resistant HIV-1 (under the brand name Sunlenca) and to prevent HIV infection (PrEP) via twice-yearly injections (under the brand name Yeztugo). It works by inhibiting the HIV-1 capsid, disrupting the virus’s lifecycle at multiple stages.

In Eastern Uganda, Lenacapavir can be got from Mbale Regional Hospital and Namakwekwe Health Centre III for Mbale City.

Tororo General Hospital, Bison HCIII and Malaba HCIII for Tororo District.

Bugiri Municipal Council HCIII for Bugiri District, Iganga General Hospital for Iganga district, Jinja Regional Referral Hospital and Bugembe HCIV for Jinja City.

Bumanya HCIV for Kaliro district, Kamuli General Hospital for Kamuli District, Baitambogwe HCIII for Mayuge, Buyinja HCIV for Namayingo and Ngora HCIV for Ngora District.

Soroti Regional Referral Hospital and Kichinjaji HCIII for Soroti City, and Nsinze HCIV for Namutumba district.

Ministry of Health says this is a phased rollout starting with high-burden districts adding that Uganda only received 19,200 doses in Feb 2026.

The Ministry expects a total of 94,560 doses which is sufficient only for about 47,000 people. However, the country requires more than 3million doses.

“The 19,200 doses have been distributed to high-burden and high-incidence districts based on need,” says MOH in a Wednesday, May 6, 2026 statement adding the Ministry is currently prioritizing places where 100+ people get HIV daily.

Phase 1 started in April 2026 with just 103 health facilities; this will be expanded to 300 facilities by December 2026.

The Ministry expects more doses in September 2026 advising those who can’t access Lenacapavir to use the existing PrEP options – Daily oral PrEP, 2-month Cabotegravir injection, and dapivirine ring available at the health centers.

The Ministry promises to increase coverage as soon as supply increases through 2026/27.